Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.423 USD | +1.93% | +4.98% | -43.74% |
Apr. 25 | Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa | CI |
Apr. 15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 800K | Sales 2025 * | 900K | Capitalization | 5.91M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -9M | EV / Sales 2024 * | 7.39 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.57 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.73
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.93% |
1 day | +0.72% | ||
1 week | +2.54% | ||
Current month | -30.65% | ||
1 month | -25.70% | ||
3 months | -34.98% | ||
6 months | -17.44% | ||
Current year | -45.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 06-07-31 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 19-09-10 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 14-01-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 06-07-31 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 09-02-28 |
Robert Rubin
BRD | Director/Board Member | 78 | 09-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.42 | +1.20% | 83 060 |
24-04-26 | 0.415 | -2.81% | 269,354 |
24-04-25 | 0.427 | +11.49% | 684,696 |
24-04-24 | 0.383 | -4.25% | 497,507 |
24-04-23 | 0.4 | -1.43% | 448,982 |
Delayed Quote Nasdaq, April 29, 2024 at 10:51 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.05% | 5.91M | |
-2.64% | 103B | |
+1.36% | 95.28B | |
+1.75% | 22.15B | |
-15.56% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+3.80% | 13.68B | |
+34.75% | 12.17B |
- Stock Market
- Equities
- SNGX Stock